
Tazome 4.5 Injection
Marketer
Medifaith Biotech
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazome 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are tailored by your physician to your condition's severity. Strict adherence to the prescribed regimen is crucial. Common adverse effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues to your doctor; dosage adjustments or alternative medications may be necessary. Under medical guidance, this injection is generally deemed safe during pregnancy and lactation.
Uses of Tazome 4.5 Injection
Infections caused by bacteria
Major Benefits of Tazome 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tazome 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazome 4.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Tazome 4.5 Injection works:
Tazome 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin combats bacterial growth by disrupting their protective barriers, crucial for their survival. Tazobactum's role is to counteract bacterial resistance mechanisms, thereby optimizing Piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Tazome 4.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazome 4.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials remains scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility studies indicate Tazome 4.5 Injection poses minimal risk during breastfeeding. Research in humans shows negligible transfer into breast milk, presenting no apparent harm to infants.
DrivingCONSULT YOUR DOCTOR
The impact of Tazome 4.5 Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Caution is advised when administering Tazome 4.5 Injection to individuals with impaired renal function. Dosage modification for Tazome 4.5 Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Tazome 4.5 Injection in individuals with liver impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Tazome 4.5 Injection :
Omit a Tazome 4.5 Injection dose? Seek medical advice immediately.
Facts to Know About Tazome 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
